• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     Health Quality Ontario (HQO) Lumbosacral dorsal rhizotomy for spastic cerebral palsy: OHTAC recommendation
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Support for the development of an S3 guideline on natural childbirth - Evidence reports]
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Monarch external trigeminal nerve stimulation for drug-refractory epilepsy
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: OHTAC recommendation
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Transcranial magnetic stimulation for major depression and schizophrenia
2017     Belgian Health Care Knowledge Centre (KCE) Anticoagulants in non-valvular atrial fibrillation
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Pressurised intraperitoneal aerosol chemotherapy (PIPAC)
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Transoral endoscopic thyroidectomy vestibular approach (TOETVA)
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Antibiotic treatment for uncomplicated acute appendicitis
2017     NIHR Health Technology Assessment programme Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Intragastric balloons for weight loss
2017     Agency for Care Effectiveness (ACE) Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Prostate artery embolisation for benign prostatic hyperplasia
2017     Agency for Care Effectiveness (ACE) Gliclazide for the treatment of type 2 diabetes mellitus
2017     National Institute for Health and Care Excellence (NICE) ENDURALIFE powered CRT-D devices for treating heart failure. NICE medical technologies guidance 33
2017     Agency for Care Effectiveness (ACE) Ustekinumab for the treatment of chronic plaque psoriasis and psoriatic arthritis
2017     NIHR Health Technology Assessment programme Etelcalcetide for treating secondary hyperparathyroidism (ID908)
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2017     National Institute for Health and Care Excellence (NICE) HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. NICE medical technologies guidance 32
2017     NIHR Health Technology Assessment programme Eluxadoline for treating irritable bowel syndrome with diarrhoea [ID870]
2017     NIHR Health Technology Assessment programme Cabozantinib for previously treated metastatic renal cell carcinoma [ID931]
2017     Agency for Care Effectiveness (ACE) Somatropin for the treatment of growth failure in children
2017     Agency for Care Effectiveness (ACE) Gemcitabine for the treatment of cancer
2017     Agency for Care Effectiveness (ACE) Sumatriptan for the treatment of acute migraine attacks
2017     NIHR Health Technology Assessment programme Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
2017     HAYES, Inc. Antibiotic-impregnated bone cement for total hip arthroplasty and other orthopedic indications
2017     Agency for Care Effectiveness (ACE) Temozolomide for the treatment of malignant glioma
2017     NIHR Health Technology Assessment programme Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial
2017     HAYES, Inc. Arthroscopic hip surgery for femoroacetabular impingement
2017     Agency for Care Effectiveness (ACE) Insulin glargine biosimilar (Basaglar) for the treatment of type 1 and type 2 diabetes mellitus
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tonsillotomy for recurrent acute tonsillitis and for hyperplasia of the tonsils]
2017     HAYES, Inc. Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in term infants
2017     Penn Medicine Center for Evidence-based Practice (CEP) Communicating with patients about pain management for acute on chronic pain
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Macitentan (pulmonary arterial hypertension) - Benefit assessment according to §35a Social Code Book V]
2017     Agency for Healthcare Research and Quality (AHRQ) Management of suspected opioid overdose with naloxone by emergency medical services personnel
2017     NIHR Health Technology Assessment programme A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
2017     NIHR Health Technology Assessment programme Is whole-colon investigation by colonoscopy, computerised tomography colonography or barium enema necessary for all patients with colorectal cancer symptoms, and for which patients would flexible sigmoidoscopy suffice? A retrospective cohort study
2017     HAYES, Inc. Comparative effectiveness review of cryoablation for primary treatment of localized prostate cancer
2017     Penn Medicine Center for Evidence-based Practice (CEP) Medications for critical care patients with alcohol withdrawal
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: statins, lipid-lowering agents and cardiovascular risk reduction]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trifluridine/tipiracil (colorectal cancer): Addendum to Commission A16-54]
2017     Agency for Healthcare Research and Quality (AHRQ) Management of uterine fibroids
2017     HAYES, Inc. Comparative effectiveness review of dry needling for indications other than neck or trapezius muscle pain in adults
2017     Penn Medicine Center for Evidence-based Practice (CEP) Strategies for transitioning adult medical-surgical inpatients with a need for mental health services to outpatient settings
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2017     HAYES, Inc. Comparative effectiveness review of mosaicplasty for treatment of articular cartilage injuries
2017     Penn Medicine Center for Evidence-based Practice (CEP) Preparation and patient education prior to colonoscopy
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Targeted lung denervation by catheter ablation in chronic obstructive lung disease: Assessments according to §137h SGB V]
2017     HAYES, Inc. Fecal calprotectin assay for monitoring postoperative recurrence of Crohn disease
2017     Penn Medicine Center for Evidence-based Practice (CEP) Needleless connectors for intravenous injections
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V]
2017     HAYES, Inc. Hydrogen breath test in patients with functional bowel disorders and suspected carbohydrate malabsorption
2017     Penn Medicine Center for Evidence-based Practice (CEP) Pathways for management of alcohol withdrawal in critical care units
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids: Assessment according to §137h Social Code Book V]
2017     Agency for Healthcare Research and Quality (AHRQ) Methods for evaluating natural experiments in obesity: a systematic evidence review
2017     HAYES, Inc. Hydrogen breath tests for diagnosis of small intestinal bacterial overgrowth in functional bowel disorders
2017     Penn Medicine Center for Evidence-based Practice (CEP) Non-pharmacologic strategies for the management of inpatient aggressive behavior
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the liver and the intrahepatic bile ducts - Assessment according to §137h Social Code Book V]
2017     NIHR Health Technology Assessment programme The Asymptomatic Carotid Surgery Trial-2 (ACST-2): an ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
2017     NIHR Health Technology Assessment programme Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs a randomised controlled feasibility trial
2017     HAYES, Inc. Intravenous lidocaine infusion for neuropathic pain: a review of reviews
2017     Penn Medicine Center for Evidence-based Practice (CEP) Hypertension in patients undergoing carotid endarterectomy
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas - Assessment according to §137h Social Code Book V]
2017     HAYES, Inc. Laparoscopic electromechanical morcellation of uterine fibroids during myomectomy orhysterectomy
2017     Penn Medicine Center for Evidence-based Practice (CEP) Patient lifestyle education for lung transplant recipients
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the bone and the joint cartilage: Assessment according to §137h Social Code Book V]
2017     NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2017     NIHR Health Technology Assessment programme A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities
2017     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2017     Penn Medicine Center for Evidence-based Practice (CEP) Heparin flush for central and peripheral venous access devices
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the bone - Assessment according to §137h Social Code Book V]
2017     NIHR Health Technology Assessment programme Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica
2017     Penn Medicine Center for Evidence-based Practice (CEP) High-dose Vitamin C for treatment of sepsis
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the liver and the intrahepatic bile ducts - Assessment according to §137h Social Code Book V]
2017     HAYES, Inc. Roux-en-Y gastric bypass for treatment of Type II Diabetes: a review of reviews
2017     Penn Medicine Center for Evidence-based Practice (CEP) Peer specialists in crisis response centers
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Procedure for lung volume reduction in severe lung emphysema]
2017     HAYES, Inc. Surgical treatment for lymphedema: a review of reviews
2017     Penn Medicine Center for Evidence-based Practice (CEP) APSO vs. SOAP structure for progress notes
2017     Health Information and Quality Authority (HIQA) Health technology assessment of a national emergency endovascular service for mechanical thrombectomy in the management of acute ischaemic stroke
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Olaratumab (sarcoma) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2017     NIHR Health Technology Assessment programme Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model
2017     HAYES, Inc. Comparative effectiveness review of dry needling for mechanical neck and/or trapezius muscle pain in adults
2017     Penn Medicine Center for Evidence-based Practice (CEP) Oral antibiotics for secondary prophylaxis following two-stage revision surgery for prosthetic joint infection
2017     Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of smoking cessation interventions
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Opicapone (Parkinson disease): Addendum to Commission A16-61]
2017     NIHR Health Technology Assessment programme Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2017     Penn Medicine Center for Evidence-based Practice (CEP) Association of hats with risk of SIDS in newborns
2017     Health Information and Quality Authority (HIQA) Health technology assessment of human papillomavirus testing as the primary screening method for prevention of cervical cancer
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ceritinib (lung cancer): Addendum to Commission A16-62]
2017     NIHR Health Technology Assessment programme Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
2017     Penn Medicine Center for Evidence-based Practice (CEP) Family presence during resuscitation
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of exome sequencing for diagnosed dismorphic syndromes, with or without intellectual disabilities. Literature review
2017     Health Information and Quality Authority (HIQA) Health technology assessment evaluating the treatment and transport options for Priority 1 transfer patients
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines
2017     Penn Medicine Center for Evidence-based Practice (CEP) Productivity and access measures for primary care
2017     Andalusian Health Technology Assessment Area (AETSA) Assessment of efficacy, effectiveness and safety of transcranial doppler ultrasonography in acute ischaemic stroke
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elbasvir/grazoprevir (chronic hepatitis C): Benefit assessment according to §35a Social Code Book V]